Document:

Exhibit
4.14

 

GENERATION
ALPHA, INC.

 

WARRANT
TO PURCHASE COMMON STOCK

 

	Warrant
    No. 2021-01	 	Original
    Issue Date: March 30, 2021

 

Generation
Alpha, Inc., a Nevada corporation (the “Company”), hereby certifies that, for value received, Sichenzia
Ross Ference LLP or its permitted registered assigns (the “Holder”), is entitled to purchase from the
Company up to a total of 4,000,000 shares of common stock, $0.001 par value per share (the “Common Stock”),
of the Company (each such share, a “Warrant Share” and all such shares, the “Warrant Shares”)
at an exercise price per share equal to $0.001 per share (as adjusted from time to time as provided in Section 9 herein,
the “Exercise Price”), upon surrender of this Warrant to Purchase Common Stock (including any Warrants
to Purchase Common Stock issued in exchange, transfer or replacement hereof, the “Warrant”) at any time
and from time to time on or after March 30, 2021 (the “Original Issue Date”) and through and including
5:30 P.M., New York City time, on March 30, 2026 (the “Expiration Date”), and subject to the following
terms and conditions:

 

1.
Definitions. For purposes of this Warrant, the following terms shall have the following meanings:

 

(a)
“Affiliate” means any Person directly or indirectly controlled by, controlling or under common control with,
a Holder, but only for so long as such control shall continue. For purposes of this definition, “control” (including,
with correlative meanings, “controlled by,” “controlling” and “under common control with”)
means, with respect to a Person, possession, direct or indirect, of (a) the power to direct or cause direction of the management
and policies of such Person (whether through ownership of securities or partnership or other ownership interests, by contract
or otherwise), or (b) at least 50% of the voting securities (whether directly or pursuant to any option, warrant or other similar
arrangement) or other comparable equity interests.

 

(b)
“Commission” means the United States Securities and Exchange Commission.

 

(c)
“Closing Sale Price” means, for any security as of any date, the last trade price for such security on the
Principal Trading Market for such security, as reported by Nasdaq.com, or, if such Principal Trading Market begins to operate
on an extended hours basis and does not designate the last trade price, then the last trade price of such security prior to 4:00
P.M., New York City time, as reported by Nasdaq.com, or if the foregoing do not apply, the last trade price of such security in
the over-the-counter market on the electronic bulletin board for such security as reported by Bloomberg Financial Markets, or,
if no last trade price is reported for such security by Bloomberg Financial Markets, the average of the bid and ask prices, of
any market makers for such security as reported in the “pink sheets” by Pink Sheets LLC. If the Closing Sale Price
cannot be calculated for a security on a particular date on any of the foregoing bases, the Closing Sale Price of such security
on such date shall be the fair market value as mutually determined by the Company and the Holder. If the Company and the Holder
are unable to agree upon the fair market value of such security, then the Board of Directors of the Company shall use its good
faith judgment to determine the fair market value. The determination of the Board of Directors of the Company shall be binding
upon all parties absent demonstrable error. All such determinations shall be appropriately adjusted for any stock dividend, stock
split, stock combination or other similar transaction during the applicable calculation period.

 

(d)
“Principal Trading Market” means the national securities exchange or other trading market on which the Common
Stock is primarily listed on and quoted for trading, which, as of the Original Issue Date, shall be the OTCQB.

 

(e)
“Securities Act” means the Securities Act of 1933, as amended.

 

(f)
“Trading Day” means any weekday on which the Principal Trading Market is open for trading.

 

    	 

    	 

    

 

(g)
“Transfer Agent” means Action Stock Transfer Corp., the Company’s transfer agent and registrar for the
Common Stock, and any successor appointed in such capacity.

 

2.
Registration of Warrants. The Company shall register this Warrant, upon records to be maintained by or on behalf of the
Company for that purpose (the “Warrant Register”), in the name of the record Holder (which shall include
the initial Holder or, as the case may be, any registered assignee to which this Warrant is permissibly assigned hereunder) from
time to time. The Company may deem and treat the registered Holder of this Warrant as the absolute owner hereof for the purpose
of any exercise hereof or any distribution to the Holder, and for all other purposes, absent actual notice to the contrary.

 

3.
Registration of Transfers. Subject to compliance with all applicable securities laws, the Company shall, or will cause
its Transfer Agent to, register the transfer of all or any portion of this Warrant in the Warrant Register, upon surrender of
this Warrant, and payment for all applicable transfer taxes (if any). Upon any such registration or transfer, a new warrant to
purchase Common Stock in substantially the form of this Warrant (any such new warrant, a “New Warrant”)
evidencing the portion of this Warrant so transferred shall be issued to the transferee, and a New Warrant evidencing the remaining
portion of this Warrant not so transferred, if any, shall be issued to the transferring Holder. The acceptance of the New Warrant
by the transferee thereof shall be deemed the acceptance by such transferee of all of the rights and obligations in respect of
the New Warrant that the Holder has in respect of this Warrant. The Company shall, or will cause its Transfer Agent to, prepare,
issue and deliver at the Company’s own expense any New Warrant under this Section 3. Until due presentment for registration
of transfer, the Company may treat the registered Holder hereof as the owner and holder for all purposes, and the Company shall
not be affected by any notice to the contrary.

 

4.
Exercise and Duration of Warrants.

 

(a)
All or any part of this Warrant shall be exercisable by the registered Holder in any manner permitted by Section 10 of
this Warrant at any time and from time to time on or after the Original Issue Date and through and including 5:30 P.M., New York
City time, on the Expiration Date, subject to the conditions and restrictions contained in this Warrant. At 5:30 P.M., New York
City time, on the Expiration Date, the portion of this Warrant not exercised prior thereto shall be and become void and of no
value and this Warrant shall be terminated and no longer outstanding.

 

(b)
The Holder may exercise this Warrant by delivering to the Company (i) an exercise notice, in the form attached as Schedule
1 hereto (the “Exercise Notice”), completed and duly signed, and (ii) payment of the Exercise Price
for the number of Warrant Shares as to which this Warrant is being exercised (which may take the form of a “cashless exercise”
if so indicated in the Exercise Notice pursuant to Section 10 below), and the date on which the last of such items is delivered
to the Company (as determined in accordance with the notice provisions hereof) is an “Exercise Date.” The Holder
shall not be required to deliver the original Warrant in order to effect an exercise hereunder. Execution and delivery of the
Exercise Notice shall have the same effect as cancellation of the original Warrant and issuance of a New Warrant evidencing the
right to purchase the remaining number of Warrant Shares.

 

5.
Delivery of Warrant Shares.

 

(a)
Upon exercise of this Warrant, the Company shall promptly (but in no event later than two Trading Days after the Exercise Date),
upon the request of the Holder, credit such aggregate number of shares of Common Stock to which the Holder is entitled pursuant
to such exercise to the Holder’s or its designee’s balance account with The Depository Trust Company (“DTC”)
through its Deposit Withdrawal Agent Commission system, or if the Transfer Agent is not participating in the Fast Automated Securities
Transfer Program (the “FAST Program”), issue and dispatch by overnight courier to the address as specified
in the Exercise Notice, a certificate, registered in the Company’s share register in the name of the Holder or its designee,
for the number of shares of Common Stock to which the Holder is entitled pursuant to such exercise. The Holder, or any natural
person or legal entity (each, a “Person”) permissibly so designated by the Holder to receive Warrant
Shares, shall be deemed to have become the holder of record of such Warrant Shares as of the Exercise Date, irrespective of the
date such Warrant Shares are credited to the Holder’s or the Holder’s designee’s DTC account or the date of
delivery of the certificates evidencing such Warrant Shares, as the case may be.

 

    	2

    	 

    

 

(b)
To the extent permitted by law, the Company’s obligations to issue and deliver Warrant Shares in accordance with and subject
to the terms hereof (including the limitations set forth in Section 12 below) are absolute and unconditional, irrespective
of any action or inaction by the Holder to enforce the same, any waiver or consent with respect to any provision hereof, the recovery
of any judgment against any Person or any action to enforce the same. Nothing herein shall limit the Holder’s right to pursue
any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance
and/or injunctive relief with respect to the Company’s failure to timely deliver the Warrant Shares upon exercise of the
Warrant as required pursuant to the terms hereof.

 

6.
Charges, Taxes and Expenses. Issuance and delivery of the Warrant Shares upon exercise of this Warrant shall be made without
charge to the Holder for any issue or transfer tax, transfer agent fee or other incidental tax or expense in respect of the issuance
of the Warrant Shares, all of which taxes and expenses shall be paid by the Company; provided, however, that the
Company shall not be required to pay any tax that may be payable in respect of any transfer involved in the registration of Warrant
Shares or the Warrants in a name other than that of the Holder or an Affiliate thereof. The Holder shall be responsible for all
other tax liabilities that may arise as a result of holding or transferring this Warrant or receiving Warrant Shares upon exercise
hereof.

 

7.
Replacement of Warrant. If this Warrant is mutilated, lost, stolen or destroyed, the Company shall issue or cause to be
issued in exchange and substitution for and upon cancellation hereof, or in lieu of and substitution for this Warrant, a New Warrant,
but only upon receipt of evidence reasonably satisfactory to the Company of such loss, theft or destruction (in such case) and,
in each case, a customary and reasonable indemnity and surety bond, if requested by the Company. Applicants for a New Warrant
under such circumstances shall also comply with such other reasonable regulations and procedures and pay such other reasonable
third-party costs as the Company may prescribe. If a New Warrant is requested as a result of a mutilation of this Warrant, then
the Holder shall deliver such mutilated Warrant to the Company as a condition precedent to the Company’s obligation to issue
the New Warrant.

 

8.
Reservation of Warrant Shares. The Company covenants that it will at all times reserve and keep available out of the aggregate
of its authorized but unissued and otherwise unreserved Common Stock, solely for the purpose of enabling it to issue Warrant Shares
upon exercise of this Warrant as herein provided, the number of Warrant Shares that are initially issuable and deliverable upon
the exercise of this entire Warrant, free from preemptive rights or any other contingent purchase rights of persons other than
the Holder (taking into account the adjustments and restrictions of Section 9). The Company covenants that all Warrant
Shares so issuable and deliverable shall, upon issuance and the payment of the applicable Exercise Price (or upon a “cashless
exercise” pursuant to Section 10) in accordance with the terms hereof, be duly and validly authorized, issued and
fully paid and nonassessable. The Company will take all commercially reasonable actions as may be necessary to assure that such
shares of Common Stock may be issued as provided herein without violation of any applicable law or regulation, or of any requirements
of any securities exchange or automated quotation system upon which the Common Stock may be listed.

 

9.
Certain Adjustments. The Exercise Price and number of Warrant Shares issuable upon exercise of this Warrant are subject
to adjustment from time to time as set forth in this Section 9.

 

(a)
Stock Dividends and Splits. If the Company, at any time while this Warrant is outstanding, (i) pays a stock dividend on
its Common Stock or otherwise makes a distribution on any class of capital stock that is payable in shares of Common Stock, (ii)
subdivides its outstanding shares of Common Stock into a larger number of shares, or (iii) combines its outstanding shares of
Common Stock into a smaller number of shares, then in each such case, the Exercise Price shall be multiplied by a fraction, the
numerator of which shall be the number of shares of Common Stock outstanding immediately before such event and the denominator
of which shall be the number of shares of Common Stock outstanding immediately after such event. Any adjustment made pursuant
to clause (i) of this paragraph shall become effective immediately after the record date for the determination of stockholders
entitled to receive such dividend or distribution, and any adjustment pursuant to clause (ii) or (iii) of this paragraph shall
become effective immediately after the effective date of such subdivision or combination.

 

    	3

    	 

    

 

(b)
Pro Rata Distributions. If the Company, at any time while this Warrant is outstanding, distributes to all holders of Common
Stock for no consideration (i) evidences of its indebtedness, (ii) any security (other than a distribution of Common Stock covered
by the preceding paragraph), (iii) rights or warrants to subscribe for or purchase any security, or (iv) any other asset (in each
case, “Distributed Property”), then, upon any exercise of this Warrant that occurs after the record date fixed
for determination of stockholders entitled to receive such distribution, the Holder shall be entitled to receive, in addition
to the Warrant Shares otherwise issuable upon such exercise (if applicable), the Distributed Property that such Holder would have
been entitled to receive in respect of such number of Warrant Shares had the Holder been the record holder of such Warrant Shares
immediately prior to such record date without regard to any limitation on exercise contained therein. Notwithstanding anything
herein to the contrary, the foregoing provisions in this Section 9(b) shall not apply to, or be triggered by, any rights
issued by the Company (either separately or that attach to any securities of the Company) in connection with any stockholders
rights agreement, poison pill or other similar anti-takeover provision under the Company’s certificate of incorporation,
bylaws or other documents.

 

(c)
Fundamental Transactions. If, at any time while this Warrant is outstanding, the Company effects a “Fundamental
Transaction” (to be defined as (i) any merger or consolidation of the Company with or into another Person, (ii) any
sale of all or substantially all of the Company’s and its subsidiaries’ assets, taken as a whole, (iii) any reclassification
of the Common Stock (other than a change to par value, or from par value to no par value or changes resulting from a combination
or subdivision), or (iv) any statutory exchange of the outstanding shares of Common Stock, as a result of which, the holders of
the Common Stock would be entitled to receive, or their Common Stock would be converted into, or exchanged for, shares, stock,
other securities, or other property or assets (including cash or any combination thereof), then, to the extent then permitted
under applicable laws, rules and regulations (including the rules of the Nasdaq Stock Market or any exchange on which the Common
Stock is then listed), upon any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant
Share that would have been issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction, the
same kind and amount of securities, cash, assets or property as it would have been entitled to receive upon the occurrence of
such Fundamental Transaction if it had been, immediately prior to such Fundamental Transaction, the holder of the number of Warrant
Shares then issuable upon exercise in full of this Warrant without regard to any limitations on exercise contained herein (the
“Alternate Consideration”), and after receipt of such Alternate Consideration, the obligations of the
Company, surviving entity or corporation purchasing or otherwise acquiring such assets or other appropriate corporation or Person
shall be deemed satisfied in full and this Warrant terminated with respect to the portion so exercised. The Company shall not
effect any such Fundamental Transaction unless prior to or simultaneously with the consummation thereof, any successor to the
Company, surviving entity or the corporation purchasing or otherwise acquiring such assets or other appropriate corporation or
Person shall assume the obligation to deliver to the Holder, such Alternate Consideration as, in accordance with the foregoing
provisions, the Holder may be entitled to receive, and the other obligations under this Warrant. The provisions of this Section
9(c) shall similarly apply to subsequent transactions analogous of a Fundamental Transaction type.

 

(d)
Number of Warrant Shares. Simultaneously with any adjustment to the Exercise Price pursuant to paragraph (a) of this Section
9, the number of Warrant Shares that may be purchased upon exercise of this Warrant shall be increased or decreased proportionately,
so that after such adjustment the aggregate Exercise Price payable hereunder for the increased or decreased number of Warrant
Shares shall be the same as the aggregate Exercise Price in effect immediately prior to such adjustment.

 

(e)
Calculations. All calculations under this Section 9 shall be rounded down to the nearest whole cent or the nearest
whole share, as applicable.

 

    	4

    	 

    

 

(f)
Notice of Adjustments. Upon the occurrence of each adjustment pursuant to this Section 9, the Company at its expense
will, at the written request of the Holder, promptly compute such adjustment, in good faith, in accordance with the terms of this
Warrant and prepare a certificate setting forth such adjustment, including a statement of the adjusted Exercise Price and adjusted
number or type of Warrant Shares or other securities issuable upon exercise of this Warrant (as applicable), describing the transactions
giving rise to such adjustments and showing in detail the facts upon which such adjustment is based. Upon written request, the
Company will promptly deliver a copy of each such certificate to the Holder and to the Company’s transfer agent.

 

(g)
Notice of Corporate Events. If, while this Warrant is outstanding, the Company (i) declares a dividend or any other distribution
of cash, securities or other property in respect of its Common Stock, including, without limitation, any granting of rights or
warrants to subscribe for or purchase any capital stock of the Company or any subsidiary, (ii) authorizes or approves, enters
into any agreement contemplating or solicits stockholder approval for any Fundamental Transaction or (iii) authorizes the voluntary
dissolution, liquidation or winding up of the affairs of the Company, then, except if such notice and the contents thereof shall
be deemed to constitute material non-public information, the Company shall deliver to the Holder a notice of such transaction
at least five (5) Trading Days prior to the applicable record or effective date on which a Person would need to hold Common Stock
in order to participate in or vote with respect to such transaction; provided, however, that the failure to deliver such notice
or any defect therein shall not affect the validity of the corporate action required to be described in such notice. In addition,
if while this Warrant is outstanding, the Company authorizes or approves, enters into any agreement contemplating or solicits
stockholder approval for any Fundamental Transaction contemplated by Section 9(c), other than a Fundamental Transaction under
clause (iii) of Section 9(c), the Company shall deliver to the Holder a notice of such Fundamental Transaction at least ten (10)
Trading Days prior to the date such Fundamental Transaction is consummated. To the extent that any notice provided hereunder constitutes,
or contains, material, non-public information regarding the Company or any of its subsidiaries, the Company shall simultaneously
file such notice with the Commission pursuant to a Current Report on Form 8-K.

 

10.
Payment of Exercise Price. The Holder shall pay the Exercise Price in immediately available funds by wire transfer to an
account designated by the Company; provided, however, that upon the Holder’s election, the Holder may, in its sole discretion,
satisfy its obligation to pay the Exercise Price through a “cashless exercise”, in which event the Company shall issue
to the Holder the number of Warrant Shares determined as follows:

 

X
= Y [(A-B)/A]

 

where:

 

“X”
equals the number of Warrant Shares to be issued to the Holder;

 

“Y”
equals the total number of Warrant Shares with respect to which this Warrant is being exercised;

 

“A”
is the Closing Sale Price of the shares of Common Stock (as reported by Nasdaq.com) on the Trading Day ending on the date immediately
preceding the Exercise Date (the “Fair Market Value”); and

 

“B”
equals the Exercise Price then in effect for the applicable Warrant Shares at the time of such exercise.

 

For
purposes of Rule 144 promulgated under the Securities Act, it is intended, understood and acknowledged that the Warrant Shares
issued in a “cashless exercise” transaction shall be deemed to have been acquired by the initial Holder, and the holding
period for the Warrant Shares shall be deemed to have commenced, on the date this Warrant was originally issued (provided that
the Commission continues to take the position that such treatment is proper at the time of such exercise).

 

    	5

    	 

    

 

11.
Limitation on Exercises. The Company shall not affect the exercise of this Warrant, and the Holder shall not have the right
to exercise this Warrant, to the extent that after giving effect to such exercise, the Holder (together with such Holder’s
affiliates) would beneficially own in excess of 4.99% of the shares of Common Stock outstanding immediately after giving effect
to such exercise. For purposes of the foregoing sentence, the aggregate number of shares of Common Stock beneficially owned by
such Holder and its affiliates shall include the number of shares of Common Stock issuable upon exercise of this Warrant with
respect to which the determination of such sentence is being made, but shall exclude shares of Common Stock which would be issuable
upon (A) exercise of the remaining, unexercised portion of this Warrant beneficially owned by such Holder and its affiliates and
(B) exercise or conversion of the unexercised or unconverted portion of any other securities of the Company beneficially owned
by such Person and its affiliates (including, without limitation, any convertible notes or convertible preferred stock or warrants)
subject to a limitation on conversion or exercise analogous to the limitation contained herein. Except as set forth in the preceding
sentence, for purposes of this paragraph, beneficial ownership shall be calculated in accordance with Section 13(d) of the Securities
Exchange Act of 1934, as amended. To the extent that the limitation contained in this Section 11 applies, the determination of
whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any affiliate) and of which
portion of this Warrant is exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise
shall be deemed to be the Holder’s determination of whether this Warrant is exercisable (in relation to other securities
owned by the Holder together with any affiliate) and of which portion of this Warrant is exercisable, in each case subject to
such aggregate percentage limitation, and the Company shall have no obligation to verify or confirm the accuracy of the determination.
For purposes of this Warrant, in determining the number of outstanding shares of Common Stock, the Holder may rely on the number
of outstanding shares of Common Stock as reflected in (1) the Company’s most recent Form 10-K, Form 10-Q, Current Report
on Form 8-K or other public filing with the Securities and Exchange Commission, as the case may be, (2) a more recent public announcement
by the Company or (3) any other notice by the Company setting forth the number of shares of Common Stock outstanding. For any
reason at any time, upon the written or oral request of the Holder, the Company shall within one (1) business day confirm orally
and in writing to the Holder the number of shares of Common Stock then outstanding. In any case, the number of outstanding shares
of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the Company, including
this Warrant, by the Holder and its affiliates since the date as of which such number of outstanding shares of Common Stock was
reported. The restriction described in this Section 11 may be waived, in whole or in part, upon sixty-one (61) days prior notice
from the Holder to the Company to increase such percentage up to 9.99%, but not in excess of 9.99%. The provisions of this paragraph
shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 11 to correct
this paragraph (or any portion hereof) which may be defective or inconsistent with the intended beneficial ownership limitation
herein contained or to make changes or supplements necessary or desirable to properly give effect to such limitation

 

12.
[Reserved.]

 

13.
No Fractional Shares. No fractional Warrant Shares will be issued in connection with any exercise of this Warrant. In lieu
of any fractional shares that would otherwise be issuable, the number of Warrant Shares to be issued shall be rounded down to
the next whole number and the Company shall pay the Holder in cash the fair market value (based on the Closing Sale Price) for
any such fractional shares.

 

14.
Notices. Any and all notices or other communications or deliveries hereunder (including, without limitation, any Exercise
Notice) shall be in writing and shall be deemed given and effective on the earliest of (i) the date of transmission, if such notice
or communication is delivered via facsimile or confirmed e-mail at the facsimile number or e-mail address specified below prior
to 5:30 P.M., New York City time, on a Trading Day, (ii) the next Trading Day after the date of transmission, if such notice or
communication is delivered via facsimile or confirmed e-mail at the facsimile number or e-mail address specified below on a day
that is not a Trading Day or later than 5:30 P.M., New York City time, on any Trading Day, (iii) the Trading Day following the
date of mailing, if sent by nationally recognized overnight courier service specifying next business day delivery, or (iv) upon
actual receipt by the Person to whom such notice is required to be given, if by hand delivery.

 

    	6

    	 

    

 

15.
Warrant Agent. The Company shall serve as warrant agent under this Warrant. Upon fifteen (15) days’ notice to the
Holder, the Company may appoint a new warrant agent. Any corporation into which the Company or any new warrant agent may be merged
or any corporation resulting from any consolidation to which the Company or any new warrant agent shall be a party or any corporation
to which the Company or any new warrant agent transfers substantially all of its corporate trust or stockholders services business
shall be a successor warrant agent under this Warrant without any further act. Any such successor warrant agent shall promptly
cause notice of its succession as warrant agent to be mailed (by first class mail, postage prepaid) to the Holder at the Holder’s
last address as shown on the Warrant Register.

 

16.
Miscellaneous.

 

(a)
No Rights as a Stockholder. The Holder, solely in such Person’s capacity as a holder of this Warrant, shall not be
entitled to vote or receive dividends or be deemed the holder of share capital of the Company for any purpose, nor shall anything
contained in this Warrant be construed to confer upon the Holder, solely in such Person’s capacity as the Holder of this
Warrant, any of the rights of a stockholder of the Company or any right to vote, give or withhold consent to any corporate action
(whether any reorganization, issue of stock, reclassification of stock, consolidation, merger, amalgamation, conveyance or otherwise),
receive notice of meetings, receive dividends or subscription rights, or otherwise, prior to the issuance to the Holder of the
Warrant Shares which such Person is then entitled to receive upon the due exercise of this Warrant. In addition, nothing contained
in this Warrant shall be construed as imposing any liabilities on the Holder to purchase any securities (except upon exercise
of this Warrant or otherwise) or as a stockholder of the Company, whether such liabilities are asserted by the Company or by creditors
of the Company.

 

(b)
No Avoidance. Except and to the extent as waived or consented to by the Holder, the Company shall not by any action, including,
without limitation, amending its certificate or articles of incorporation or through any reorganization, transfer of assets, consolidation,
merger, dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance
of any of the terms of this Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the
taking of all such actions as may be necessary or appropriate to protect the rights of Holder as set forth in this Warrant against
impairment. Without limiting the generality of the foregoing, the Company will (a) not increase the par value of any Warrant Shares
above the amount payable therefor upon such exercise immediately prior to such increase in par value, (b) take all such action
as may be necessary or appropriate in order that the Company may validly and legally issue fully paid and nonassessable Warrant
Shares upon the exercise of this Warrant, and (c) use commercially reasonable efforts to obtain all such authorizations, exemptions
or consents from any public regulatory body having jurisdiction thereof as may be necessary to enable the Company to perform its
obligations under this Warrant.

 

(c)
Successors and Assigns. Subject to the restrictions on transfer set forth in this Warrant and the restrictions on transfer
set forth in this Warrant and compliance with applicable securities laws, this Warrant may be assigned by the Holder. This Warrant
may not be assigned by the Company without the written consent of the Holder except to a successor in the event of a Fundamental
Transaction. This Warrant shall be binding on and inure to the benefit of the Company and the Holder and their respective successors
and assigns. Subject to the preceding sentence, nothing in this Warrant shall be construed to give to any Person other than the
Company and the Holder any legal or equitable right, remedy or cause of action under this Warrant. This Warrant may be amended
only in writing signed by the Company and the Holder, or their successors and assigns.

 

(d)
Amendment and Waiver. Except as otherwise provided herein, the provisions of the Warrants may be amended and the Company
may take any action herein prohibited, or omit to perform any act herein required to be performed by it, only if the Company has
obtained the written consent of the Holders of Warrants representing no less than a majority of the Warrant Shares obtainable
upon exercise of the Warrants then outstanding.

 

(e)
Acceptance. Receipt of this Warrant by the Holder shall constitute acceptance of and agreement to all of the terms and
conditions contained herein.

 

    	7

    	 

    

 

(f)
Governing Law; Jurisdiction. ALL QUESTIONS CONCERNING THE CONSTRUCTION, VALIDITY, ENFORCEMENT AND INTERPRETATION OF THIS
WARRANT SHALL BE GOVERNED BY AND CONSTRUED AND ENFORCED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK WITHOUT REGARD TO
THE PRINCIPLES OF CONFLICTS OF LAW THEREOF. EACH OF THE COMPANY AND THE HOLDER HEREBY IRREVOCABLY SUBMITS TO THE EXCLUSIVE JURISDICTION
OF THE STATE AND FEDERAL COURTS SITTING IN THE CITY OF NEW YORK, BOROUGH OF MANHATTAN, FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER
OR IN CONNECTION HEREWITH OR WITH ANY TRANSACTION CONTEMPLATED HEREBY OR DISCUSSED HEREIN (INCLUDING WITH RESPECT TO THE ENFORCEMENT
OF ANY OF THE TRANSACTION DOCUMENTS), AND HEREBY IRREVOCABLY WAIVES, AND AGREES NOT TO ASSERT IN ANY SUIT, ACTION OR PROCEEDING,
ANY CLAIM THAT IT IS NOT PERSONALLY SUBJECT TO THE JURISDICTION OF ANY SUCH COURT. EACH OF THE COMPANY AND THE HOLDER HEREBY IRREVOCABLY
WAIVES PERSONAL SERVICE OF PROCESS AND CONSENTS TO PROCESS BEING SERVED IN ANY SUCH SUIT, ACTION OR PROCEEDING BY MAILING A COPY
THEREOF VIA REGISTERED OR CERTIFIED MAIL OR OVERNIGHT DELIVERY (WITH EVIDENCE OF DELIVERY) TO SUCH PERSON AT THE ADDRESS IN EFFECT
FOR NOTICES TO IT AND AGREES THAT SUCH SERVICE SHALL CONSTITUTE GOOD AND SUFFICIENT SERVICE OF PROCESS AND NOTICE THEREOF. NOTHING
CONTAINED HEREIN SHALL BE DEEMED TO LIMIT IN ANY WAY ANY RIGHT TO SERVE PROCESS IN ANY MANNER PERMITTED BY LAW. EACH OF THE COMPANY
AND THE HOLDER HEREBY WAIVES ALL RIGHTS TO A TRIAL BY JURY.

 

(g)
Headings. The headings herein are for convenience only, do not constitute a part of this Warrant and shall not be deemed
to limit or affect any of the provisions hereof.

 

(h)
Severability. In case any one or more of the provisions of this Warrant shall be invalid or unenforceable in any respect,
the validity and enforceability of the remaining terms and provisions of this Warrant shall not in any way be affected or impaired
thereby, and the Company and the Holder will attempt in good faith to agree upon a valid and enforceable provision which shall
be a commercially reasonable substitute therefor, and upon so agreeing, shall incorporate such substitute provision in this Warrant.

 

[REMAINDER
OF PAGE INTENTIONALLY LEFT BLANK]

 

    	8

    	 

    

 

IN
WITNESS WHEREOF, the Company has caused this Warrant to be duly executed by its authorized officer as of the date first indicated
above.

 

	 	GENERATION
    ALPHA, INC.
	 	 
	 	By:	 
	 	Name:	Tiffany
    Davis
	 	Title:	Chief
    Executive Officer

 

    	9

    	 

    

 

SCHEDULE
1

 

FORM
OF EXERCISE NOTICE

 

[To
be executed by the Holder to purchase shares of Common Stock under the Warrant]

 

Ladies
and Gentlemen:

 

(1)
The undersigned is the Holder of Warrant No. __________ (the “Warrant”) issued by Generation Alpha,
Inc., a Nevada corporation (the “Company”). Capitalized terms used herein and not otherwise defined herein
have the respective meanings set forth in the Warrant.

 

(2)
The undersigned hereby exercises its right to purchase __________ Warrant Shares pursuant to the Warrant.

 

(3)
The Holder intends that payment of the Exercise Price shall be made as (check one):

 

	 	[  ]	Cash
    Exercise; or
	 	 	 
	 	[  ]	“Cashless
    Exercise” under Section 10 of the Warrant.

 

(4)
If the Holder has elected a Cash Exercise, the Holder shall pay the sum of $___________ in immediately available funds to the
Company in accordance with the terms of the Warrant.

 

(5)
Pursuant to this Exercise Notice, the Company shall deliver to the Holder Warrant Shares determined in accordance with the terms
of the Warrant.

 

	Dated:	 	 
	 	 	 
	Name
        of

        Holder:
	 	 
	 	 	 
	By:	 	 
	Name:	 	 
	Title:
    	 	 

 

(Signature
must conform in all respects to name of Holder as specified on the face of the Warrant)Exhibit
10.32

 

EXECUTIVE
EMPLOYMENT AGREEMENT

 

This
EXECUTIVE EMPLOYMENT AGREEMENT (the “Agreement”) dated January 1, 2021 (the “Effective Date”)
by and between Generation Alpha, a company incorporated under the laws of Nevada (the “Company”), and Tiffany
Davis, an individual (the “Executive”) with reference to the following facts:

 

WHEREAS,
Executive currently serves as the Chief Executive Officer, Chief Financial Officer and Member of the Board of Directors of the
Company;

 

WHEREAS,
the Company wishes to retain Executive as its Chief Executive Officer, Chief Financial Officer and Member of the Board of Directors;
and

 

WHEREAS,
the parties wish to enter into this Agreement directly between Executive and the Company, on the terms and conditions contained
in this Agreement, which will supersede all prior agreements and understandings between the Company and Executive, oral or written
with respect to its subject matter.

 

NOW
THEREFORE, in consideration of the mutual covenants contained herein, the parties, intending to be legally bound, agree as follows:

 

1.
Definitions. As used in this Agreement, the following terms shall have the following meanings:

 

(a)
“Board” means the Board of Directors of the Company.

 

(b)
“Cause” means any of the following:

 

	 	(i)	the
    commission of an act of fraud, embezzlement or dishonesty by Executive, or the commission of some other illegal act by Executive
    (other than traffic violations or other offenses or violations outside of the course of Executive’s employment), that
    has a demonstrable material adverse impact on the Company or any successor or affiliate thereof, provided however,
    that no act shall be deemed an illegal act, if such act would otherwise be legal, but for 21 U.S.C. § 801 et seq.
    (a/k/a the “Controlled Substances Act”).
	 	 	 
	 	(ii)	a
    conviction of, or plea of “guilty” or “no contest” to, a felony by Executive;
	 	 	 
	 	(iii)	any
    unauthorized use or disclosure by Executive of confidential information or trade secrets of the Company or any successor or
    affiliate thereof that has, or may reasonably be expected to have, a material adverse impact on any such entity;

 

    	1

    	 

    

 

	 	(iv)	Executive’s
    gross negligence, failure to follow a material, lawful and reasonable request of the Board or material violation of any duty
    of loyalty to the Company or any successor or affiliate thereof, or any other demonstrable material willful misconduct on
    the part of Executive;
	 	 	 
	 	(v)	Executive’s
    ongoing and repeated failure or refusal to perform or neglect of Executive’s duties as required by this Agreement, which
    failure, refusal or neglect continues for thirty (30) days following Executive’s receipt of written notice from the
    Board stating with specificity the nature of such failure, refusal or neglect; or
	 	 	 
	 	(vi)	Executive’s
    material breach of any Company policy or any material provision of this Agreement;

 

provided,
however, that prior to the determination that “Cause” under this Section 1(b) has occurred, the Board shall
(A) provide to Executive in writing, in reasonable detail, the reasons for the determination that such “Cause” exists,
(B) other than with respect to clause (v) above which specifies the applicable period of time for Executive to remedy his breach,
afford Executive a reasonable opportunity to remedy any such breach, (C) provide Executive an opportunity to be heard by the Board
(with counsel present) prior to the final decision to terminate Executive’s employment hereunder for such “Cause”
and (D) make any decision that such “Cause” exists in good faith and with the approval of two-thirds (2/3rds) of the
independent members of the Board. For purposes hereof, no act shall be deemed “willful” if taken (or omitted) on the
reasonable belief that it was in the best interest of the Company or upon the advice of counsel or other expert.

 

The
foregoing definition shall not in any way preclude or restrict the right of the Company or any successor or affiliate thereof
to discharge or dismiss Executive for any other acts or omissions, but such other acts or omissions shall not be deemed, for purposes
of this Agreement, to constitute grounds for termination for Cause.

 

(c)
Change in Control. For purposes of this Agreement, “Change in Control” means the first to occur of any
of the following transactions that also constitutes a change in the ownership or effective control of the Company, or a change
in the ownership of a substantial portion of the Company’s assets, as described in Treasury Regulation Section 1.409A-3(i)(5):
(A) a merger or consolidation in which the Company is not the surviving entity, except for a transaction the principal purpose
of which is to change the state in which the Company is incorporated; (B) the sale, transfer or other disposition of all or substantially
all of the assets of the Company (including the capital stock of the Company’s subsidiary corporations); (C) the complete
liquidation or dissolution of the Company; (D) any reverse merger in which the Company is the surviving entity but in which securities
possessing more than fifty percent (50%) of the total combined voting power of the Company’s outstanding securities are
transferred to a person or persons different from those who held such securities immediately prior to such merger; or (E) an acquisition
of the Company in a single or series of related transactions by any person or related group of persons (other than the Company
or by a Company-sponsored employee benefit plan) of beneficial ownership (within the meaning of Rule 13d-3 of the Exchange Act)
of securities possessing more than fifty percent (50%) of the total combined voting power of the Company’s outstanding securities.
Notwithstanding anything to the contrary contained herein, the following transactions shall not constitute a Change in Control
hereunder: (i) a sale by the Company of its securities in a bona fide financing transaction; and (ii) a sale of assets, merger
or other transaction effected exclusively for the purpose of changing the domicile of the Company. To the extent required for
compliance with Section 409A of the Internal Revenue Code, in no event will a Change in Control be deemed to have occurred if
such transaction is not also a “change in the ownership or effective control of” the Company or “a change in
the ownership of a substantial portion of the assets of” the Company as determined under Treasury Regulations Section 1.409A-3(i)(5)
(without regard to any alternative definition thereunder).

 

    	2

    	 

    

 

Benefits
upon a Change in Control. In the event of a Change in Control of the Company, the vesting and/or exercisability of twenty-five
percent (25%) of the outstanding unvested equity awards then held by Executive (the “Equity Awards”) shall
be accelerated as of immediately prior to the effective date of the Change of Control transaction. Further, in the event that
the Equity Awards are not assumed or substituted and would otherwise terminate prior to and in connection with the Change in Control,
the vesting and/or exercisability of an additional fifty percent (50%) of the Equity Awards shall be accelerated as of immediately
prior to the effective date of the Change of Control transaction.

 

(d)
“Code” means the Internal Revenue Code of 1986, as amended from time to time, and the Treasury Regulations
and other interpretive guidance issued thereunder.

 

(e)
“Good Reason” means the occurrence of any of the following events or conditions without Executive’s written
consent:

 

	 	(i)	a
    material reduction of Executive’s title, authority, duties or responsibilities, or the assignment to Executive of duties
    materially inconsistent with Executive’s positions with the Company as stated in Section 2(a) hereof, provided, however,
    that the Company’s appointment of someone as Chief Financial Officer and removing such title, authority, duties and/or
    responsibilities associated with that title from Executive shall not constitute Good Reason;
	 	 	 
	 	(ii)	a
    material diminution in Executive’s base compensation, unless a similar reduction is imposed across-the-board to senior
    management of the Company and is not greater than 15%;
	 	 	 
	 	(iii)	a
    material change in the geographic location at which Executive must perform his duties (and the parties acknowledge that a
    relocation of Executive’s principal office to a location more than twenty-five (25) miles from the Company’s then
    current offices (excepting reasonable travel on the Company’s business) shall constitute a material change for purposes
    of this clause (iii));

 

    	3

    	 

    

 

	 	(iv)	any
    other action or inaction that constitutes a material breach by the Company or any successor or affiliate of its obligations
    to Executive under this Agreement; or
	 	 	 
	 	(v)	the
    Company’s delivery of a Non-Renewal Notice (as hereinafter defined).

 

Executive
must provide written notice to the Company of the occurrence of any of the foregoing events or conditions without Executive’s
written consent within ninety (90) days of the occurrence of such event. The Company or any successor or affiliate shall have
a period of thirty (30) days to cure such event or condition after receipt of written notice of such event from Executive. “Good
Reason” shall not exist unless and until the Company fails to cure the condition within the allotted timeframe.

 

(f)
“Involuntary Termination” means (i) Executive’s Separation from Service by reason of Executive’s
discharge by the Company other than for Cause, or (ii) Executive’s Separation from Service by reason of Executive’s
resignation of employment with the Company for Good Reason. Executive’s Separation from Service by reason of Executive’s
death or discharge by the Company following Executive’s Permanent Disability shall not constitute an Involuntary Termination.
Executive’s Separation from Service by reason of resignation from employment with the Company for Good Reason shall be an
“Involuntary Termination” only if such Separation from Service occurs within six (6) months following the initial
existence of the act or failure to act constituting Good Reason, and then only after an opportunity to cure has been provided
in accordance with Section 1(d).

 

(g)
“Involuntary Termination” means (i) Executive’s Separation from Service by reason of Executive’s
discharge by the Company (or its successor(s) within twelve (12) months following a Change in Control) other than for Cause, or
(ii) Executive’s Separation from Service by reason of Executive’s resignation of employment with the Company (or its
successor(s) within twelve (12) months following a Change in Control) for Good Reason. Executive’s Separation from Service
by reason of Executive’s death or discharge by the Company following Executive’s Permanent Disability shall not constitute
an Involuntary Termination. Executive’s Separation from Service by reason of resignation from employment with the Company
for Good Reason shall be an “Involuntary Termination” only if such Separation from Service occurs within six (6) months
following the initial existence of the act or failure to act constituting Good Reason, and then only after an opportunity to cure
has been provided in accordance with Section 1(d), or within twelve (12) months following a Change in Control, as provided for
hereinabove in this Sub-section.

 

(h)
“Permanent Disability” of Executive shall be deemed to have occurred if Executive shall become physically or
mentally incapacitated or disabled or otherwise unable fully to discharge his duties hereunder for a period of ninety (90) consecutive
calendar days or for one hundred twenty (120) calendar days in any one hundred eighty (180) calendar-day period. The existence
of Executive’s Permanent Disability shall be determined by the Company on the advice of a physician chosen by the Company
and the Company reserves the right to have Executive examined by a physician chosen by the Company at the Company’s expense.

 

    	4

    	 

    

 

(i)
“Separation from Service,” with respect to Executive, means Executive’s “separation from service,”
as defined in Treasury Regulation Section 1.409A-1(h).

 

(j)
“Stock Awards” means all stock options, restricted stock and such other awards granted pursuant to the Company’s
stock option and equity incentive award plans or agreements and any shares of stock issued upon exercise thereof.

 

2.
Services to Be Rendered.

 

(a)
Duties and Responsibilities. Executive shall serve as Chief Executive Officer, and Chief Financial Officer of the Company.
The Company shall continue to nominate and recommend that Executive serve as a director on the Board. In the performance of such
duties, Executive shall report directly to and shall be subject to the direction of the Board. Executive hereby consents to serve
as an officer and/or director of the Company or any subsidiary or affiliate thereof without any additional salary or compensation.
Executive’s primary place of work shall be southern California. Executive shall be subject to and comply with the policies
and procedures generally applicable to senior executives of the Company to the extent the same are not inconsistent with any term
of this Agreement.

 

(b)
Exclusive Services. Executive shall at all times faithfully, industriously and to the best of her ability, experience and
talent perform to the satisfaction of the Board all of the duties that may be assigned to Executive hereunder and shall devote
substantially all of her productive time and efforts to the performance of such duties. Executive agrees that she will not join
any boards, other than community and civic boards (which do not interfere with her duties to the Company), without the prior approval
of the Board, such approval not to be unreasonably withheld or delayed. Except as provided below, the Company shall be entitled
to all benefits, profits or other issues arising from or incidental to all work, services and advice performed or provided by
Executive. Provided that the activities listed below do not materially interfere with Executive’s duties and responsibilities
to the Company and are not otherwise prohibited by this Agreement, nothing in this Agreement shall preclude Employee from:

 

	 	(i)	Serving
    as a member or owner of any organization involving no conflict of interest with the Company, provided that Executive must
    obtain the prior written approval of the Board, which approval shall not be unreasonably withheld or delayed. Ownership in
    her CBD business is so approved;
	 	 	 
	 	(ii)	Serving
    as a consultant in her area of expertise to government, commercial and academic panels where it does not conflict with the
    interests of the Company; and
	 	 	 
	 	(iii)	Managing
    her personal investments, including owning shares of companies whose securities are publicly traded, so long as such securities
    do not constitute more than five percent (5%) of the outstanding securities of any such company.

 

    	5

    	 

    

 

3.
Compensation and Benefits. The Company shall pay or provide, as the case may be, to Executive the compensation and other
benefits and rights set forth in this Section 3.

 

(a)
Base Salary. As of the Effective Date, the Company shall pay to Executive a base salary (the “Base Salary”)
of $175,000 per year, payable in accordance with the Company’s usual pay practices (and in any event no less frequently
than monthly).

 

(b)
Annual Salary Increase. Executive’s Base Salary shall be subject to review annually by the Board and/or the Compensation
Committee and may be increased but not decreased.

 

(c)
Annual Bonus. Executive shall be entitled to participate in any bonus plan that the Board and/or Compensation Committee
of the Board or its designee may approve for the senior executives of the Company. Any bonus awarded under this Section 3(c) shall
be calculated following the close of the fiscal year to which the bonus relates and paid in a lump sum by no later than two and
one-half (2 1⁄2) months following the end of the fiscal year in which such bonus award is earned, provided that Executive
remains employed on the date of payment (and has not given notice of resignation).

 

(d)
Year End Bonus. The Company and Executive agree that the year-end bonus will be $30,000 and will be paid no later than
March 15, 2021.

 

(e)
Performance-Based Bonus. In addition to any other compensation that Executive is entitled to under this Agreement, and
subject to the conditions set forth in this Section 3(d), the Company shall pay to Executive an annual performance-based bonus
(the “Performance-Based Bonus”) as follows:

 

	 	(i)	If
    the Company’s total 2021 gross, top-line revenue for the fiscal year in which such bonus award is earned has increased
    by at least Thirty-Three percent (33%) from the prior fiscal year of 2020, Executive shall receive thirty percent (30%) of
    the Base Salary for the fiscal year in which such bonus award is earned,
	 	 	 
	 	(ii)	If
    the Company’s total 2021 gross, top line revenue for the fiscal year in which such bonus award is earned has increased
    by at least Sixty-Six percent (66%) from the prior fiscal year, Executive shall receive fifty percent (50%) of the Base Salary
    for the fiscal year in which such bonus award is earned,

 

Any
Performance-Based Bonus awarded under this Section 3(d) shall be calculated following the close of the fiscal year to which the
bonus relates, and paid in a lump sum by no later than two and one-half (2 1⁄2) months following the end of the fiscal year
in which such bonus award is earned, provided that Executive remains employed on the date of payment (and has not given notice
of resignation).

 

    	6

    	 

    

 

(e)
Equity Awards. The Company shall grant to Executive an option to purchase $12,500 of the Company’s common stock exercisable,
for a five (5) year period from the date of each grant, at 100 percent (100%) of the closing price on the last trading day preceding
the first (1st ), second (2nd), third (3rd), and forth (4th) Quarters of the Effective
Date, respectively. Executive has the right to execute such options on a “net exercise” or similar “cashless”
conversion. Executive shall also be entitled to participate in any equity or other employee benefit plan that is generally available
to senior executive officers, as distinguished from general management, of the Company. Except as otherwise provided in this Agreement,
Executive’s participation in and benefits under any such plan shall be on the terms and subject to the conditions specified
in the governing document of the particular plan.

 

(f)
Benefits. Executive shall be entitled to participate in benefits under the Company’s benefit plans, profit sharing
and arrangements, including, without limitation, any employee benefit plan or arrangement made available in the future by the
Company to its employees or senior executives, subject to and on a basis consistent with the terms, conditions and overall administration
of such plans and arrangements. The Company shall have the right to amend or delete any such benefit plan or arrangement made
available by the Company to its employees or senior executives and not otherwise specifically provided for herein. Notwithstanding
the foregoing, during the Employment Term (as hereinafter defined), the Company will provide, at the Company’s expense,
health and major medical insurance benefits to the Executive.

 

(g)
Expenses. The Company shall promptly reimburse Executive for reasonable out-of-pocket business expenses incurred in connection
with the performance of her duties hereunder, subject to (i) such policies as the Company may from time to time establish, (ii)
Executive furnishing the Company with evidence in the form of receipts satisfactory to the Company substantiating the claimed
expenditures, and (iii) Executive receiving advance approval from the Board in the case of expenses (or a series of related expenses)
in excess of $1000.

 

(h)
Paid Time Off. Executive shall have the right to four weeks of Personal Time Off (“PTO”) during each successive
one-year period of her employment by the Company, which PTO time shall be taken at such time or times in each such one-year period
so as not to materially and adversely interfere with the performance of her responsibilities under this Agreement. Executive shall
not be entitled to carry over any unused vacation time from one year to the next and any accrued but unused vacation time will
be waived. In addition, Executive shall be entitled to paid Holidays in accordance with the policies of the Company applicable
to senior management personnel from time to time.

 

(i)
Withholding. The Company shall be entitled to withhold from amounts payable or benefits accorded to Executive under this
Agreement all federal, state and local income, employment and other taxes, as and in such amounts as may be required by applicable
law.

 

4.
Employment Term. The term of this Agreement (as it may be extended by the following sentence or terminated earlier pursuant
to Section 5, the (“Employment Term”) shall begin on the Effective Date and end on the first (1st)
anniversary of the Effective Date. The Employment Term shall be automatically extended for additional one-year periods unless,
at least sixty (60) days prior to the end of the expiration of the Employment Term, Executive or the Board notifies the other
party in writing (a “Non-Renewal Notice”) that it does not wish to extend such Employment Term. Executive’s
employment hereunder shall be coterminous with the Employment Term, unless sooner terminated as provided in Section 5.

 

    	7

    	 

    

 

5.
Termination; Severance. Executive shall be entitled to receive benefits upon a Separation from Service only as set forth
in this Section 5:

 

(a)
General. Either the Board or Executive may terminate Executive’s employment hereunder, for any reason, at any time
prior to the expiration of the Employment Term, upon thirty (30) days prior written notice to the other party. Upon termination
of Executive’s employment hereunder for any reason, Executive shall be deemed simultaneously to have resigned from any other
position or office he may at the time hold with the Company or any of its affiliates. In addition, upon termination of Executive’s
employment hereunder for any reason, including, without limitation, expiration of the Employment Term, the Company shall (i) reimburse
Executive for any expenses properly incurred under Section 3(g) and which have not previously been reimbursed as of the effective
date of the termination, and (ii) pay Executive for any other accrued and unpaid compensation under Section 3, including, but
not limited to, Base Salary through and including the effective date of termination (the “Termination Date”)
(collectively, the “Accrued Compensation”). The Accrued Compensation will be paid in a lump sum on the Termination
Date or on the first business day after the Termination Date, if the Termination Date falls on a weekend or holiday.

 

(b)
Separation from Service by Death or Following Permanent Disability. Subject to Sections 5(e) and 10(p) and Executive’s
continued compliance with Section 6, in the event of Executive’s Separation from Service as a result of Executive’s
death or discharge by the Company following Executive’s Permanent Disability, Executive or Executive’s estate, as
applicable, shall be entitled to receive her base salary through the end of the month in which Executive’s Separation from
Service occurs as a result of Executive’s death or Permanent Disability.

 

(c)
Severance upon Involuntary Termination. Subject to Sections 5(e) and 10(p) and Executive’s continued compliance with
Section 6, if Executive’s employment is Involuntarily Terminated, Executive shall be entitled to receive, in lieu of any
severance benefits to which Executive may otherwise be entitled under any severance plan or program of the Company, the benefits
provided below, which, with respect to clause (ii) and the last sentence of clause (iii) (if applicable) will be payable in a
lump sum within ten (10) days following the effective date of Executive’s Release (as hereinafter defined):

 

	 	(i)	the
    Company shall pay to Executive his fully earned but unpaid base salary, when due, through the date of Executive’s Involuntary
    Termination at the rate then in effect (without regard to any reduction in salary that gave rise to an event of Good Reason),
    plus all other benefits, if any, under any Company group retirement plan, nonqualified deferred compensation plan, equity
    award plan or agreement, health benefits plan or other Company group benefit plan to which Executive may be entitled pursuant
    to the terms of such plans or agreements at the time of Executive’s Involuntary Termination;

 

    	8

    	 

    

 

(d)
Termination for Cause or Voluntary Resignation Without Good Reason. In the event of Executive’s termination of employment
as a result of Executive’s discharge by the Company for Cause or Executive’s resignation without Good Reason (other
than as a result of Executive’s death or Separation from Service by reason of discharge by the Company following Executive’s
Permanent Disability), the Company shall not have any other or further obligations to Executive under this Agreement (including
any financial obligations) except that Executive shall be entitled to receive the Accrued Compensation. In addition, in the event
of Executive’s Separation from Service as a result of Executive’s discharge by the Company for Cause or Executive’s
resignation without Good Reason (other than as a result of Executive’s death or Separation from Service by reason of discharge
by the Company following Executive’s Permanent Disability), all vesting of Executive’s unvested Stock Awards previously
granted to him by the Company shall cease and none of such unvested Stock Awards shall be exercisable following the 90th
day following the date of such termination. The foregoing shall be in addition to, and not in lieu of, any and all other
rights and remedies which may be available to the Company under the circumstances, whether at law or in equity.

 

(e)
Termination in Connection with a Change in Control Event. Subject to Sections 5(f) and 10(p) and Executive’s continued
compliance with Section 6, if Executive’s employment is Involuntarily Terminated within twelve (12) months after consummation
of a Change in Control transaction or within ninety (90) days prior to the consummation of a Change in Control or if terminated
after an agreement has been executed that contemplates the consummation of an Change in Control but before it closes, Executive
shall be entitled to receive, in addition to (A) any severance benefits to which Executive may otherwise be entitled under any
severance plan or program of the Company and (B) pursuant to Section 5(c) hereof, the vesting and/or exercisability of any outstanding
unvested portions of such Stock Awards shall be automatically accelerated so as to be immediately vested and exercisable as of
the date of Involuntary Termination and shall remain exercisable through the Severance Period (subject to earlier termination
(A) in connection with a recapitalization or similar transaction pursuant to the Company’s equity incentive plans governing
such Stock Awards or (B) the contractual term of the Stock Award).

 

(f)
Release. As a condition to Executive’s receipt of any post-termination benefits pursuant to Sections 5(b), (c) or
(d) above, Executive (or, in the event of Executive’s incapacity as a result of his Permanent Disability, Executive’s
legal representative) shall execute and not revoke a general release of all claims in favor of the Company (the “Release”)
in a form reasonably acceptable to the Company. In the event the Release does not become effective within the fifty-five (55)
day period following the date of Executive’s Separation from Service, Executive shall not be entitled to the aforesaid payments
and benefits.

 

    	9

    	 

    

 

(g)
Exclusive Remedy. Except as otherwise expressly required by law (e.g., COBRA) or as specifically provided herein, all of
Executive’s rights to salary, severance, benefits, bonuses and other amounts hereunder (if any) accruing after the termination
of Executive’s employment shall cease upon such termination. In the event of Executive’s termination of employment
with the Company, Executive’s sole remedy shall be to receive the payments and benefits described in this Section 5. In
addition, Executive acknowledges and agrees that he is not entitled to any reimbursement by the Company for any taxes payable
by Executive as a result of the payments and benefits received by Executive pursuant to this Section 5, including, without limitation,
any excise tax imposed by Section 4999 of the Code.

 

(h)
No Mitigation. Executive shall not be required to mitigate the amount of any payment provided for in this Section 5 by
seeking other employment or otherwise, nor shall the amount of any payment or benefit provided for in this Section 5 be reduced
by any compensation earned by Executive as the result of employment by another employer or self-employment or by retirement benefits;
provided, however, that loans, advances or other amounts owed by Executive to the Company may be offset by the Company
against amounts payable to Executive under this Section 5.

 

(i)
Return of the Company’s Property. In the event of Executive’s termination of employment for any reason, the
Company shall have the right, at its option, to require Executive to vacate his offices prior to or on the effective date of separation
and to cease all activities on the Company’s behalf. Upon Executive’s termination of employment in any manner, as
a condition to Executive’s receipt of any severance benefits described in this Agreement, Executive shall immediately surrender
to the Company all lists, books and records of, or in connection with, the Company’s business, and all other property belonging
to the Company, it being distinctly understood that all such lists, books and records, and other documents, are the property of
the Company. Executive shall deliver to the Company a signed statement certifying compliance with this Section 5(h) prior to the
receipt of any severance benefits described in this Agreement.

 

6.
Certain Covenants.

 

(a)
Confidential Information. Executive recognizes and acknowledges that by reason of Executive’s employment by and service
to the Company before, during and, if applicable, after the Employment Term, Executive will have access to certain confidential
and proprietary information relating to the Company’s business, which may include, but is not limited to, unique business
strategies, theories and concepts, information regarding plans, strategies, opportunities, processes, ideas, research and know-how
developed by or for the Company, trade secrets, patents, other intellectual property, clinical studies, regulatory dossiers, manufacturing,
marketing, personnel, financial data, technical information, methods, processes, formulae and information which Company has obtained
from third parties (collectively referred to as “Confidential Information”). Executive acknowledges that such
Confidential Information is a valuable and unique asset of the Company and Executive covenants that he will not, unless expressly
authorized in writing by the Company, at any time during the course of Executive’s employment use any Confidential Information
or divulge or disclose any Confidential Information to any person, firm or corporation except in connection with the performance
of Executive’s duties for the Company and in a manner consistent with the Company’s policies regarding Confidential
Information. Executive also covenants that at any time after the termination of such employment, directly or indirectly, he will
not use any Confidential Information or divulge or disclose any Confidential Information to any person, firm or corporation, unless
such information is in the public domain through no fault of Executive or except when required to do so by a court of law, by
any governmental agency having supervisory authority over the business of the Company or by any administrative or legislative
body (including a committee thereof) with apparent jurisdiction to order Executive to divulge, disclose or make accessible such
information. All written Confidential Information (including, without limitation, in any computer or other electronic format)
which comes into Executive’s possession during the course of Executive’s employment shall remain the property of the
Company. Except as required in the performance of Executive’s duties for the Company, or unless expressly authorized in
writing by the Company, Executive shall not remove any written Confidential Information from the Company’s premises, except
in connection with the performance of Executive’s duties for the Company and in a manner consistent with the Company’s
policies regarding Confidential Information. Upon termination of Executive’s employment, Executive agrees to return immediately
to the Company all written Confidential Information (including, without limitation, in any computer or other electronic format)
in Executive’s possession. As a condition of Executive’s continued employment with the Company and in order to protect
the Company’s interest in such proprietary information, the Company shall be allowed to require Executive’s execution
of a confidentiality agreement and/or proprietary information and inventions agreement, as reasonably requested by the Board not
inconsistent with the provisions of this paragraph 6(b).

 

    	10

    	 

    

 

(b)
Solicitation of Employees. During the Restricted Period, Executive shall not, directly or indirectly, solicit or encourage
any person to leave the employment of the Company or any of its affiliates, any employee of the Company or any of its affiliates.

 

(c)
Solicitation of Consultants and other Third Parties. During the Restricted Period, Executive shall not, directly or indirectly,
hire, solicit or encourage any person to cease work with the Company or any of its affiliates, consultants, distributors, licensees
or other third party partners then under contract with the Company or any of its affiliates within one year of the termination
of such consultant’s engagement by the Company or any of its affiliates.

 

(d)
Rights and Remedies Upon Breach. If Executive breaches or threatens to commit a breach of any of the provisions of this
Section 6 (the “Restrictive Covenants”), the Company shall have the following rights and remedies, each of
which rights and remedies shall be independent of the other and severally enforceable, and all of which rights and remedies shall
be in addition to, and not in lieu of, any other rights and remedies available to the Company under law or in equity:

 

	 	(i)	Specific
    Performance. The right and remedy to have the Restrictive Covenants specifically enforced by any court having equity jurisdiction
    by way of a temporary restraining order, preliminary injunction, permanent injunction, or other equitable remedy, all without
    the need to post a bond or any other security or to prove any amount of actual damage or that money damages would not provide
    an adequate remedy, it being acknowledged and agreed that any such breach or threatened breach may cause irreparable injury
    to the Company and that money damages will not provide adequate remedy to the Company; and

 

    	11

    	 

    

 

	 	(ii)	Accounting
    and Indemnification. The right and remedy to require Executive to account for and pay over to the Company all compensation,
    profits, monies, accruals, increments or other benefits derived or received by Executive or any associated party deriving
    such benefits as a result of any such breach of the Restrictive Covenants.

 

(e)
Definitions. For purposes of this Section 6, the term “Company” means not only Generation Alpha., but
also any company, partnership or entity which, directly or indirectly, controls, is controlled by or is under common control with
Generation Alpha.

 

7.
Insurance; Indemnification.

 

(a)
Insurance. The Company shall have the right to take out life, health, accident, “key-man” or other insurance
covering Executive, in the name of the Company and at the Company’s expense in any amount deemed appropriate by the Company.
Executive shall assist the Company in obtaining such insurance, including, without limitation, submitting to any required examinations
and providing information and data required by insurance companies.

 

(b)
Indemnification. Executive will be provided with indemnification against third party claims related to his work for the
Company to the fullest extent permitted by California law. The Company shall provide Executive with directors and officers liability
insurance coverage at least as favorable as that which the Company shall maintain for members of the Board and other executive
officers.

 

8.
General Relationship. Executive shall be considered an employee of the Company within the meaning of all federal, state
and local laws and regulations including, but not limited to, laws and regulations governing unemployment insurance, workers’
compensation, industrial accident, labor and taxes.

 

9.
Representations and Warranties of Executive. Executive hereby represents and warrants to the Company that (a) the execution,
delivery and performance of this Agreement by Executive does not and shall not conflict with, breach, violate or cause a default
under any agreement, contract or instrument to which the Executive is a party or any judgment, order or decree to which Executive
is subject, (b) Executive is not a party to or bound by any employment agreement, (c) Executive is not a party to or bound by
any consulting agreement, non-compete agreement, confidentiality agreement or similar agreement with any other person or entity
that would affect the Company or the obligations of Executive hereunder and (d) upon the execution and delivery of this Agreement
by the Company and Executive, this Agreement will be a valid and binding obligation of Executive, enforceable in accordance with
its terms.

 

    	12

    	 

    

 

10.
Miscellaneous.

 

(a)
Modification; Prior Claims. This Agreement sets forth the entire understanding of the parties with respect to the subject
matter hereof, supersedes all existing agreements between them concerning such subject matter. This Agreement may be amended or
modified only with the written consent of Executive and an authorized representative of the Company. No oral waiver, amendment
or modification will be effective under any circumstances whatsoever.

 

(b)
Assignment; Assumption by Successor. The rights of the Company under this Agreement may, without the consent of Executive,
be assigned by the Company, in its sole and unfettered discretion, to any person, firm, corporation or other business entity which
at any time, (whether direct or indirect and whether by purchase, lease, merger, consolidation, liquidation or otherwise, acquires
all or substantially all of the assets or business of the Company. The Company will require any successor(s) (whether direct or
indirect, by purchase, merger or otherwise) to all or substantially all of the business or assets of the Company expressly to
assume and to agree to perform this Agreement in the same manner and to the same extent that the Company would be required to
perform it if no such succession had taken place; provided, however, that no such assumption shall relieve the Company
of its obligations hereunder. As used in this Agreement, the “Company” shall mean the Company as hereinbefore
defined and any successor to its business and/or assets as aforesaid which assumes and agrees to perform this Agreement by operation
of law or otherwise.

 

(c)
Survival. The covenants, agreements, representations and warranties contained in or made in Sections 3(e), 3(f), 5, 6,
7, 9 and 10 of this Agreement shall survive the termination of Executive’s employment.

 

(d)
Third-Party Beneficiaries. This Agreement does not create, and shall not be construed as creating, any rights enforceable
by any person not a party to this Agreement.

 

(e)
Waiver. The failure of either party hereto at any time to enforce performance by the other party of any provision of this
Agreement shall in no way affect such party’s rights thereafter to enforce the same, nor shall the waiver by either party
of any breach of any provision hereof be deemed to be a waiver by such party of any other breach of the same or any other provision
hereof.

 

(f)
Section Headings. The headings of the several sections in this Agreement are inserted solely for the convenience of the
parties and are not a part of and are not intended to govern, limit or aid in the construction of any term or provision hereof.

 

(g)
Notices. Any notice required or permitted by this Agreement shall be in writing and shall be delivered as follows with
notice deemed given as indicated: (i) by personal delivery when delivered personally; (ii) by overnight courier upon written verification
of receipt; (iii) by email, telecopy or facsimile transmission upon acknowledgment of receipt of electronic transmission; or (iv)
by certified or registered mail, return receipt requested, upon verification of receipt. Notice shall be sent to Executive at
the address listed on the Company’s personnel records and to the Company at its principal place of business, or such other
address as either party may specify in writing.

 

    	13

    	 

    

 

 

(h)
Severability. All Sections, clauses and covenants contained in this Agreement are severable, and in the event any of them
shall be held to be invalid by any court, this Agreement shall be interpreted as if such invalid Sections, clauses or covenants
were not contained herein.

 

(i)
Governing Law. This Agreement shall be governed by, and construed in accordance with and subject to, the laws of the State
of California applicable to agreements made and to be performed entirely within such state without regard to its conflicts of
law rules.

 

(j)
Jurisdiction and Venue.

 

	 	(i)
    	The
    Company and Executive hereby irrevocably and unconditionally submit, for themselves and their property, to the exclusive jurisdiction
    of the California State courts or the United States District Court for the Central District of California, and any appellate
    court from any thereof, in any action or proceeding arising out of or relating to this Agreement or for recognition or enforcement
    of any judgment, and the Company and Executive hereby irrevocably and unconditionally agree that all claims in respect of
    any such action or proceeding may be heard and determined in any such California State court or, to the extent permitted by
    law, in the United States District Court for the Central District of California. The Company and Executive irrevocably waive,
    to the fullest extent permitted by law, the defense of an inconvenient forum to the maintenance of such action or proceeding
    in any such court. The Company and Executive agree that a final judgment in any such action or proceeding shall be conclusive
    and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by law.

 

(k)
Non-transferability of Interest. None of the rights of Executive to receive any form of compensation payable pursuant to
this Agreement shall be assignable or transferable except through a testamentary disposition or by the laws of descent and distribution
upon the death of Executive. Any attempted assignment, transfer, conveyance, or other disposition (other than as aforesaid) of
any interest in the rights of Executive to receive any form of compensation to be made by the Company pursuant to this Agreement
shall be void.

 

(l)
Gender. Where the context so requires, the use of the masculine gender shall include the feminine and/or neuter genders
and the singular shall include the plural, and vice versa, and the word “person” shall include any corporation, firm,
partnership or other form of association.

 

(m)
Counterparts. The parties may execute this Agreement in multiple counterparts, each of which constitutes an original as
against the party that signed it, and both of which together constitute one agreement. The signatures of both parties need not
appear on the same counterpart. In the event that any signature is delivered by facsimile transmission or by an e-mail which contains
a portable document format (.pdf) file of an executed signature page, such signature page shall create a valid and binding obligation
of the party executing (or on whose behalf such signature is executed) with the same force and effect as if such signature page
were an original thereof.

 

    	14

    	 

    

 

(n)
Construction. The language in all parts of this Agreement shall in all cases be construed simply, according to its fair
meaning, and not strictly for or against any of the parties hereto. Without limitation, there shall be no presumption against
any party on the ground that such party was responsible for drafting this Agreement or any part thereof.

 

(o)
Withholding and other Deductions. All compensation payable to Executive hereunder shall be subject to such deductions as
the Company is from time to time required to make pursuant to law, governmental regulation or order.

 

(p)
Code Section 409A.

 

	 	(i)	This
    Agreement is not intended to provide for any deferral of compensation subject to Section 409A of the Code, and, accordingly,
    the severance payments payable under Sections 5(c)(ii) and 5(c)(iii) shall be paid no later than the later of: (A) the fifteenth
    (15th) day of the third month following Executive’s first taxable year in which such severance benefit is no longer
    subject to a substantial risk of forfeiture, and (B) the fifteenth (15th) day of the third month following first taxable year
    of the Company in which such severance benefit is no longer subject to substantial risk of forfeiture, as determined in accordance
    with Code Section 409A and any Treasury Regulations and other guidance issued thereunder. To the extent applicable, this Agreement
    shall be interpreted in accordance with Code Section 409A and Department of Treasury regulations and other interpretive guidance
    issued thereunder.
	 	 	 
	 	(ii)	If
    Executive is a “specified employee” (as defined in Section 409A of the Code), as determined by the Company in
    accordance with Section 409A of the Code, on the date of Executive’s Separation from Service, to the extent that the
    payments or benefits under this Agreement are subject to Section 409A of the Code and the delayed payment or distribution
    of all or any portion of such amounts to which Executive is entitled under this Agreement is required in order to avoid a
    prohibited distribution under Section 409A(a)(2)(B)(i) of the Code, then such portion deferred pursuant to this Section 9(p)(ii)
    shall be paid or distributed to Executive in a lump sum on the earlier of (A) the date that is six (6)-months following Executive’s
    Separation from Service, (B) the date of Executive’s death or (C) the earliest date as is permitted under Section 409A
    of the Code. Any remaining payments due under the Agreement shall be paid as otherwise provided herein.

 

    	15

    	 

    

 

	 	(iii)	To
    the extent applicable, this Agreement shall be interpreted in accordance with the applicable exemptions from Section 409A
    of the Code. If Executive and the Company determine that any payments or benefits payable under this Agreement intended to
    comply with Sections 409A(a)(2), (3) and (4) of the Code do not comply with Section 409A of the Code, Executive and the Company
    agree to amend this Agreement, or take such other actions as Executive and the Company deem reasonably necessary or appropriate,
    to comply with the requirements of Section 409A of the Code and the Treasury Regulations thereunder (and any applicable transition
    relief) while preserving the economic agreement of the parties. To the extent that any provision in this Agreement is ambiguous
    as to its compliance with Section 409A of the Code, the provision shall be read in such a manner that no payments payable
    under this Agreement shall be subject to an “additional tax” as defined in Section 409A(a)(1)(B) of the Code.
	 	 	 
	 	(iv)	Any
    reimbursement of expenses or in-kind benefits payable under this Agreement shall be made in accordance with Treasury Regulation
    Section 1.409A-3(i)(1)(iv) and shall be paid on or before the last day of Executive’s taxable year following the taxable
    year in which Executive incurred the expenses. The amount of expenses reimbursed or in-kind benefits payable in one year shall
    not affect the amount eligible for reimbursement or in-kind benefits payable in any other taxable year of Executive’s,
    and Executive’s right to reimbursement for such amounts shall not be subject to liquidation or exchange for any other
    benefit.
	 	 	 
	 	(v)	In
    the event that the amounts payable under Sections 5(c)(ii) and 5(c)(iii) are subject to Section 409A of the Code and the timing
    of the delivery of Executive’s Release could cause such amounts to be paid in one or another taxable year, then notwithstanding
    the payment timing set forth in such sections, such amounts shall not be payable until the later of (A) the payment date specified
    in such Section or (B) the first business day of the taxable year following Executive’s Separation from Service.

 

    	16

    	 

    

 

IN
WITNESS WHEREOF, the undersigned, intending to be legally bound, have executed this Agreement as of the date first written above.

 

	EXECUTIVE:	 	GENERATION
    ALPHA
	 	 	 
	/s/
    TIFFANY DAVIS	 	/s/
    GEORGE O’LEARY
	Tiffany
    Davis	 	Name:
                                         George O’Leary

        Title:
        Executive Chairman

 

    	17

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00326-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00326-of-00352.parquet"}]]